Pen kit box
From $132.80
- What you get
- The reusable pen, 1 dual-chamber vial, 12 needles and a booklet, in the VETUD box
- BAC water
- Included, in the cartridge
3 / 5
VTD-TES · Performance & growth
GHRH analogue studied in growth-hormone and visceral-fat research.
$132.80
Regular price $166.00
20% offPen kit box · 10 mg
Free standard shipping on orders over $200
Choose a format
Amount
In the box · Pen kit box
VETUD box with the reusable pen body, 1 dual-chamber vial (lyophilized peptide in one chamber, bacteriostatic water in the other), 12 disposable needles and an instruction booklet
All Products listed on this site are for research purposes only. All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.
A growth-hormone-releasing medicine studied for changes in visceral fat, the deep fat around the organs.
Egrifta is approved in the US for a narrowly defined prescription indication involving excess abdominal fat. It is not approved for general weight-loss management.
Tesamorelin is a stabilized copy of growth-hormone-releasing hormone (GHRH).
It raises the body’s own growth hormone, which helps break down visceral fat, the deep fat packed around the organs.
Tesamorelin: 26-week randomized clinical trial ↗
Falutz et al. · New England Journal of Medicine · 2007
Egrifta SV prescribing information ↗
FDA-approved labeling · DailyMed
Scientific background concerns the named molecule. Batch composition and analytical results must be established from the product documentation. All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.
SKUVTD-TES-VIAL-10MG, VTD-TES-PEN-10MG, VTD-TES-VIAL-20MG, VTD-TES-BOX-10MG, VTD-TES-PEN-20MG, VTD-TES-BOX-20MG
Follow the manufacturer's batch-specific storage temperature and conditions.
Keep in original packaging, away from direct sunlight and excess heat.
Refer to the lot-specific expiry date and stability documentation. Shelf life should not be inferred from the product name alone.
For solvent compatibility or preparation specifications, request the manufacturer’s batch documentation. Research protocols should be established by qualified laboratory personnel.
Every product comes three ways. It's the same peptide and the same amounts; what changes is the packaging, what's included and the price. Start with the pen kit box, which has the reusable pen, then refill it with dual-chamber vials.
From $132.80
From $100.80
From $68.80
The freeze-dried peptide and the bacteriostatic (BAC) water sit in separate chambers, divided by a rubber stopper. They stay apart until the cartridge is used.
The pen kit box has the reusable pen body with a dual-chamber vial, 12 disposable needles and a booklet. The drive, dial and indicator window stay with the pen: when a cartridge is empty, fit a new dual-chamber vial.
Choose the vial if you already have bacteriostatic water and your own lab supplies. It's the lowest price for the same amount.
Related
Blend of a GHRH analogue and a ghrelin-receptor agonist for growth-hormone research.
Pen kit box / Dual-chamber vial / Vial · 10 mg (5 mg + 5 mg)
From$67.20regular price $84.00
AvailableAll Products listed on this site are for research purposes only
Long-acting IGF-1 analogue used in cell-growth research.
Pen kit box / Dual-chamber vial / Vial · 0.1 mg / 1 mg
From$22.40regular price $28.00
AvailableAll Products listed on this site are for research purposes only
Selective ghrelin-receptor agonist studied in growth-hormone research.
Pen kit box / Dual-chamber vial / Vial · 5 mg / 10 mg
From$24.80regular price $31.00
AvailableAll Products listed on this site are for research purposes only
Education
Plain-language guides, news about new studies and selected videos from doctors and researchers. Published studies are about the named compound; they don't establish the safety or performance of this research product.
Performance & growth
Egrifta
A growth-hormone-releasing medicine studied for changes in visceral fat, the deep fat around the organs.
StudyPerformance & growth
The growth-hormone-releasing medicine is approved for a narrow use in people with HIV. A later trial measured liver fat too.
GuidePerformance & growth
These peptides prompt the body to release its own growth hormone. The human research is short and small, and sometimes concerns a different version from the one sold online.
khanacademymedicine
How the hypothalamus and pituitary coordinate hormone release, including growth and reproductive hormones.
Khan Academy · endocrine physiology
Related biology
Background on hypothalamus and pituitary signalling for understanding Tesamorelin. It does not demonstrate benefits of this compound or formulation.
American Association of Clinical Endocrinology
An overview of growth hormone deficiency and specialist care. It does not establish anti-ageing benefits or benefits of growth-hormone-releasing research peptides.
Professional endocrinology association
Related biology
Explains diagnosed growth hormone deficiency. This is different from claims about anti-ageing or unapproved growth-hormone-releasing compounds.
Ninja Nerd
A detailed lesson on growth hormone physiology and its signalling pathways.
Medical physiology education
Related biology
Background on growth hormone physiology for understanding Tesamorelin. It does not demonstrate benefits of this compound or formulation.